SEC Form 4 research

Aktis Oncology, Inc. insider transactions

Issuer	Aktis Oncology, Inc.
Tickers	AKTS
Reporting owners	28
Officers and directors	7
Last public filing	2026-09-24

Recent insider disclosures

Available	Trade date	Reporting owners	Code	Shares	Price	Reported value
2026-09-24	2026-09-23	Czibere Akos	S	7,401	$21.03	Not reported
2026-09-24	2026-09-23	Czibere Akos	S	5,099	$20.19	Not reported

Officers and directors in the directory

NODELMAN OLEG — 72 qualifying
Kim Helen Susan — 58 qualifying
EcoR1 Capital, LLC — 128 qualifying
Foley Todd — 233 qualifying
Czibere Akos — 5 qualifying
Herrmann Ken — 3 qualifying
Ron-Bigger Shulamit — 3 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.